Nasdaq

Next-Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for ...

MADISON, Wis., Oct. 22, 2023 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced late-breaking data from the pivotal ...
ascopubs.org

Improving the Sensitivity-Specificity Balance of Human Papillomavirus Testing on Self- and Clinician-Collected Samples in South Africa

Women living with and without HIV, age 30-65 years, were recruited in South Africa. Self-collected vaginal samples and clinician-collected cervical samples were tested with Xpert HPV, an assay that ...
Nasdaq

Next-generation Cologuard Test Demonstrates 94 Percent Sensitivity for Colorectal Cancer at 91 Percent Specificity, Raising the Bar in Non-invasive Screening

Note: specificity including non-advanced findings includes colonoscopy results that were negative for cancer or advanced precancer upon histopathological review; specificity including no findings ...
BMJ

2.21 The test-retest reliability, sensitivity and specificity of the SCAT-3 for sideline testing

First Round Abstract Submissions 2) Sideline Screening 2.21 The test-retest reliability, sensitivity and specificity of the SCAT-3 for sideline testing Kimberly Harmon 1, Bridget Whelan 1, Douglas ...
Healio

Blood-based test detects CRC with 83% sensitivity, ‘could help overcome’ screening barriers

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “More than three out of four Americans who die from ...
Healio

Blood-based screening test detects CRC with nearly 80% sensitivity in average-risk adults

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Negative predictive value for nonadvanced colorectal ...